Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Drug Delivery
Inhalable insulin developed with nanotechnology
June 6th, 2005
Alveair, Coremed, Inc.'s, unmodified "needleless" yet inhalable insulin, is now the focus of a global pharma consortium's plans that soon could introduce the fast-onset, long-lasting nanotechnology drug delivery system around the world, it was announced. A privately held drug-delivery company, Coremed, Inc., exclusively focuses on the development of inhalable and oral insulin technology. Over the past several years, the company has conducted an intensive preclinical trial of its insulin nanotechnology, which is a major breakthrough in the delivery of macromolecules and protein drugs. The technology formulates unmodified protein molecules into...
Source: Biotech Business Week (2005-06-06)
|
